
Ikena Oncology (IKNA) Earnings Dates & Reports
Ikena Oncology (IKNA) Most Recent Earnings
Report Date
Period EndingQ2 2025
Est. EPS-$1.56
Actual EPS-$0.72
EarningsBeat
Ikena Oncology (IKNA) Earnings
View the latest Ikena Oncology (IKNA) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Ikena Oncology (IKNA)
Order type
Buy in
Order amount
Est. shares
0 shares
Ikena Oncology (IKNA) Earnings per Share (EPS) History
Signup for full accessBrowse free
Ikena Oncology (IKNA) Latest Earnings
The value each IKNA share was expected to gain vs. the value each share gained.
Ikena Oncology (IKNA) reported its most recent earnings on for Q2 2025, posting earnings per share (EPS) of -$0.72. This exceeded analysts' expectations of -$1.56 by 53.85%, marking a Beat.
For comparison, Ikena Oncology reported EPS of -$3.36 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.
Ikena Oncology (IKNA) Earnings History
Ikena Oncology (IKNA) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Ikena Oncology’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Ikena Oncology (IKNA) Earnings FAQs
Ikena Oncology (IKNA) last reported earnings on Jul 24, 2025 for Q2 2025, posting an EPS of -$0.72, which Beat the estimate of -$1.56 by 53.85%.
For Q2 2025, Ikena Oncology (IKNA) reported an EPS of -$0.72, exceeding analysts' estimate of -$1.56 by 53.85%.
For Q2 2025, Ikena Oncology (IKNA) Beat expectations with an actual EPS of -$0.72 vs. an estimated EPS of -$1.56.
Following the last earnings report on Jul 24, 2025, Ikena Oncology (IKNA)'s stock price moved — from — to —.
The next Ikena Oncology (IKNA) earnings call is scheduled for Jul. 24, 2025, where executives will discuss financial results and outlook.